Literature DB >> 11035709

Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus.

E M Horn, R J Barst, M Poon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11035709     DOI： 10.1378/chest.118.4.1229

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  3 in total

1.  Low-dose epoprostenol improved pulmonary hypertension in a patient with systemic lupus erythematosus.

Authors:  Yoshihiro Matsukawa; Kohmei Igei; Takamasa Nozaki; Takafumi Ohki; Takako Shimizu; Noboru Kitamura; Ko Mitamura; Masami Takei; Yuji Kasamaki; Shigemasa Sawada
Journal:  Clin Rheumatol       Date:  2006-01-04       Impact factor: 2.980

Review 2.  [Pulmonary arterial hypertension in collagenoses: clinical features, epidemiology, pathogenesis, diagnosis and treatment].

Authors:  K Ahmadi-Simab; W L Gross
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

3.  Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension.

Authors:  Son-Mi Chung; Chang-Keun Lee; Eun Young Lee; Bin Yoo; Sang-Do Lee; Hee-Bom Moon
Journal:  Clin Rheumatol       Date:  2006-02-22       Impact factor: 2.980
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.